The main aim of this work is to investigate the possible anti-hyperalgesic activity of a novel CB2 selective agonist, COR167, in an animal model of peripheral neuropathy, the spared nerve injury (SNI). The gene discussed is CNR2; the disease is peripheral neuropathy.